The U.S. Food and Drug Administration (FDA) has announced the approval of Qfitlia (fitusiran), a treatment designed to ...

The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors Qfitlia (fitusiran), the first ...

Data from the ATLAS research comprises a series of trials that have yielded years of long-term, comprehensive data on safety ...

This delay in clotting is referred to as hemophilia. On Thursday, the Carbon County Commissioners recognized this disorder that affects approximately 3,000 in Pennsylvania, naming March as Bleeding ...

Sherri Ozawa, MSN, RN, told The Post that serious blood loss during menstruation could be a symptom of a blood disorder that compromises the body’s ability to form blood clots.

A recent gathering of the New Mexico bleeding disorders community provided many opportunities for support, columnist Joe MacDonald says.

These sentiments resonated as members of Sangre de Oro, the Bleeding Disorder Foundation of New Mexico, gathered for Family Education Weekend March 21-23 in Albuquerque. While many chapters around the ...

The City of College Station issued a proclamation just in time for National Bleeding Disorders Awareness Month.

Bipolar disorder is a mood disorder that includes at least one manic episode – characterized by elevated or agitated mood and often reduced need for sleep – accompanied by episodes of major ...